Comment on Potential Workflow‐ and Comparator‐Driven Bias in the Reported 24‐Hour Superiority of Dev‐ NSRAS Over Glamorgan

Key Points

• Reported superiority of Dev-NSRAS may be influenced by workflow bias, affecting interpretations.
• Caution is needed when evaluating the findings, as biases can skew reported outcomes.
• Observational analysis highlights the need for careful comparison in clinical evaluation of interventions.
• Understanding bias in reporting is critical for accurate interpretation of clinical data.

Abstract